Business:Investing
Should de-SPAC’d companies consider buying back their shares rather than making offers for their warrants? Abacus Life (NASDAQ:ABL) believes the answer is yes.
This week, we catch up with with Abacus Life Chairman and CEO Jay Jackson. He tells us why he thinks his company’s stock has managed to perform well in the six months since closing its SPAC combination and why he has taken the unorthodox decision to buy back shares rather than deal immediately with Abacus Life’s warrant overhang.
We also discuss the future of the company’s business of acquiring life insurance policies and how it is now engaging directly with policy holders and the insurance issuers as clients.
With many years at work investing in such policies, what has the data told Abacus Life about longevity and long-term health itself?
More Episodes
2023-08-02
202
2023-07-27
206
2023-06-28
231
2023-06-23
256
2023-05-24
179
2023-05-11
141
2023-04-27
267
2023-03-23
270
2023-03-22
275
2023-03-15
353
Get this podcast on your
phone, FREE
